TF and neoplasm: Having developed small-scale synthetic procedures for the three aforementioned components of the delivery system (CAL101, AD-PEG, and AD-PEG-Tf), an appropriate in vivo model was sought for a proof-of-concept investigation of the ability of this system to deliver siRNA to tumor cells in mice.